Is $2.1M too much for a drug? For affected parents, there is no debate
A decision by the drug maker Novartis to put a $2.1 million price tag on its latest product, a one-time treatment for a rare and fatal childhood disease, has sparked a national debate about just how much society should pay for the medicines it needs.
Continue Reading https://www.statnews.com
Join the Discussion